Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?

By Susva M.   Missbach M.   Green J.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 489-495

Elsevier

Access to resources Recommend Favorite

Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors

By Sawyer Tomi K  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 1-19

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of prostate cancer

By Kluetz Paul G   Figg William D   Dahut William L  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 233-247

Informa Healthcare

Access to resources Recommend Favorite

Emerging tyrosine kinase inhibitors for esophageal cancer

By Ku Geoffrey Y   Ilson David H  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 219-230

Informa Healthcare

Access to resources Recommend Favorite

Emerging tyrosine kinase inhibitors for head and neck cancer

By Bossi Paolo   Locati Laura   Licitra Lisa  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 4, 2013-12 ,pp. : 445-459

Informa Healthcare

Access to resources Recommend Favorite